openPR Logo

Press Releases from DelveInsight Business Research LLP (4784 total)

Essential Thrombocythemia Pipeline Outlook Report 2025: Advances in Research, Tr …

DelveInsight's, "Essential Thrombocythemia Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Essential Thrombocythemia pipeline landscape. It covers the

Alzheimer's Disease Pipeline Assessment Report 2025: Companies, Drugs in Develop …

DelveInsight's, "Alzheimer's disease Pipeline Insight, 2025" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer's disease pipeline landscape. It covers the

Hepatocellular Carcinoma Pipeline Drugs Report 2025: Current Trials, Key Pharma …

DelveInsight's, "Hepatocellular Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the

Cholangiocarcinoma Pipeline Drugs Report 2025: Innovations Shaping the Future of …

DelveInsight's, "Cholangiocarcinoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma Pipeline

B-Cell Lymphoma Pipeline Insights Report 2025: Latest Updates on Therapeutics an …

DelveInsight's, "B-cell Lymphoma Pipeline Insight, 2025" report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the

Bladder Cancer Pipeline Outlook Report 2025: Detailed Insights into Market Dynam …

DelveInsight's "Bladder Cancer Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers

Asthma Pipeline Outlook Report 2025: Market Trends, Drug Development, and Clinic …

DelveInsight's "Asthma Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Asthma pipeline landscape. It covers the Asthma pipeline

Liver Cancer Pipeline Drugs Report 2025: Companies, Drugs in Development, and Fu …

DelveInsight's "Liver Cancer Pipeline Insights 2025" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the

Relapsing Refractory Multiple Myeloma Pipeline Drugs Assessment 2025: Advances i …

DelveInsight's, "Relapsed/Refractory Multiple Myeloma Pipeline Insight, 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Relapsed/Refractory Multiple Myeloma pipeline landscape. It

Vitiligo Pipeline Outlook 2025: Key Players, Innovations, and Market Outlook | D …

DelveInsight's, "Vitiligo Pipeline Insight, 2025" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Vitiligo pipeline landscape. It covers the Vitiligo pipeline

Diabetic Macular Edema Pipeline Drugs 2025: Emerging Therapies and Latest Clinic …

DelveInsight's "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in the Diabetic Macular Edema pipeline landscape.

Colorectal Cancer Pipeline Drugs in Development Signal Major Shifts in the Treat …

DelveInsight's, "Colorectal Cancer Pipeline Insight 2025" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It covers the

Idiopathic Pulmonary Fibrosis Pipeline Clinical Trial Insights Reveal Breakthrou …

DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insights 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It

Small Cell Lung Cancer Pipeline Clinical Trials Highlight Promising Drugs in Dev …

DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline

Myelofibrosis Pipeline Outlook 2025: Insights Into Therapies, Research, and Mark …

DelveInsight's, "Myelofibrosis Pipeline Insights 2025" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline

Vascular Malformations Pipeline Outlook 2025: Insights Into Therapies, Research, …

DelveInsight's, "Vascular Malformations Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Vascular Malformations pipeline landscape. It covers the

Systemic Sclerosis Pipeline Outlook 2025: Insights Into Therapies, Research, and …

DelveInsight's, "Systemic Sclerosis Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Systemic Sclerosis pipeline landscape. It covers the

Polycystic Kidney Disease Pipeline Outlook 2025: Insights Into Therapies, Resear …

DelveInsight's, "Polycystic Kidney Diseases Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Polycystic Kidney Diseases pipeline landscape. It

Chronic Obstructive Pulmonary Disease Treatment Market Size Report 2034: Insight …

DelveInsight's "Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the COPD, historical and forecasted epidemiology

Dry Eye Syndrome Treatment Market Size Report 2034: Insights Into Therapies, Res …

DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the DED, historical and forecasted epidemiology as

Major Depressive Disorder Pipeline Outlook 2025: Insights Into Therapies, Resear …

DelveInsight's "Major Depressive Disorder Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape.

Pompe Disease Pipeline Outlook 2025: Insights Into Therapies, Research, and Mark …

DelveInsight's, "Pompe Disease Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Pompe Disease pipeline landscape. It covers the

Retinal Vein Occlusion Pipeline Outlook 2025: Insights Into Therapies, Research, …

DelveInsight's "Retinal Vein Occlusion Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape.

Duchenne Muscular Dystrophy Pipeline Outlook 2025: Insights Into Therapies, Rese …

DelveInsight's "Duchenne Muscular Dystrophy Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape.

Microbiome Disease Pipeline Outlook 2025: Insights Into Therapies, Research, and …

DelveInsight's, "Microbiome Disease Pipeline Insights 2025" report provides comprehensive insights about 140+ companies and 180+ pipeline drugs in Microbiome Disease pipeline landscape. It covers the

Atopic Dermatitis Pipeline Outlook 2025: Insights Into Therapies, Research, and …

DelveInsight's, "Atopic Dermatitis Pipeline Insight, 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Atopic Dermatitis pipeline landscape. It covers the

Chronic Kidney Disease Pipeline Outlook 2025: Insights Into Therapies, Research, …

DelveInsight's, "Chronic Kidney Disease Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape.

Multiple Sclerosis Pipeline Outlook 2025: Insights Into Therapies, Research, and …

DelveInsight's, "Multiple sclerosis Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the

ALK+ NSCLC Pipeline Outlook 2025: Insights Into Therapies, Research, and Market …

DelveInsight's, "ALK+ NSCLC Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK+ NSCLC pipeline landscape. It covers the

Advanced Melanoma Pipeline Outlook 2025: Insights Into Therapies, Research, and …

DelveInsight's, "Advanced Melanoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the

Adenoid Cystic Carcinoma Pipeline Outlook 2025: Insights Into Therapies, Researc …

DelveInsight's, "Adenoid Cystic Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It

Acral Lentiginous Melanoma Pipeline Appears Robust With 3+ Key Pharma Companies …

DelveInsight's, "Acral Lentiginous Melanoma Pipeline Insight 2025" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Acral Lentiginous Melanoma pipeline landscape. It

HPK1 Inhibitors Pipeline Appears Robust With 8+ Key Pharma Companies Actively Wo …

DelveInsight's, "HPK1 inhibitors Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in HPK1 inhibitors pipeline landscape. It covers the

Genital Warts Pipeline Insights Report 2025 | DelveInsight

DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight

DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape.

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight

DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …

DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as

Post-Traumatic Stress Disorder Pipeline Outlook Report 2025 | DelveInsight

DelveInsight's, "Post-Traumatic Stress Disorder (PTSD) Pipeline Insight, 2025," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Post-Traumatic Stress Disorder (PTSD) pipeline

ALK+ NSCLC Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approva …

DelveInsight's, "ALK+ NSCLC Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK+ NSCLC pipeline landscape. It covers the

Advanced Melanoma Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA …

DelveInsight's, "Advanced Melanoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the

Adenoid Cystic Carcinoma Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDM …

DelveInsight's, "Adenoid Cystic Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It

Acral Lentiginous Melanoma Pipeline Outlook 2025: Clinical Trial Studies, EMA, P …

DelveInsight's, "Acral Lentiginous Melanoma Pipeline Insight 2025" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Acral Lentiginous Melanoma pipeline landscape. It

HPK1 Inhibitors Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Ap …

DelveInsight's, "HPK1 inhibitors Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in HPK1 inhibitors pipeline landscape. It covers the

Embolic Protection Devices Market is expected to rise at a CAGR of 7.58% by 2032 …

The global embolic protection devices market was valued at USD 648.51 million in 2024 and is projected to reach USD 1,161.31 million by 2032, advancing

Electrosurgical Devices Market is expected to rise at a CAGR of 6.64% by 2032, e …

The global electrosurgical devices market was valued at USD 8,520.99 million in 2023 and is projected to grow at a CAGR of 6.64% from 2024

Enzyme Contract Manufacturing Market is expected to rise at a CAGR of 8.31% by 2 …

The global enzyme contract manufacturing market was valued at USD 2,248.05 million in 2022 and is projected to grow at a CAGR of 8.31% between

Cardiac Rhythm Management Devices Market is expected to rise at a CAGR of 8.35% …

The global cardiac rhythm management devices market is projected to grow at a CAGR of 5.64% between 2024 and 2030. This growth is driven by

Stereotactic Surgery Devices Market is expected to rise at a CAGR of 5.37% by 20 …

The global stereotactic surgery devices market is expected to grow at a CAGR of 5.37% between 2024 and 2030. Growth is primarily driven by the

Blood and Fluid Warming Medical Devices Market is expected to rise at a CAGR of …

The global blood and fluid warming medical devices market is projected to grow at a CAGR of 6.49% between 2024 and 2030. Growth is being

Audiology Devices Market is expected to rise at a CAGR of 5.63% by 2032, estimat …

The audiology devices market, valued at USD 8.23 billion in 2023, is projected to reach USD 11.42 billion by 2030, growing at a CAGR of

Go To Page:   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20